Drug Information

Drug General Information
Drug ID
D02RVN
Former ID
DIB010636
Drug Name
Selurampanel
Synonyms
BGG-492; BGG-492A; AMPA antagonist (oral, epilepsy), Novartis
Drug Type
Small molecular drug
Indication Epilepsy [ICD10:G40] Phase 2 [523372]
Company
Novartis pharmaceuticals
Formula
C16H19N5O4S
Canonical SMILES
CS(=O)(=O)Nn1c(=O)[nH]c2c(c1=O)cc(c(c2)C(C)C)c1n(ncc1)C
CAS Number
CAS 912574-69-7
PubChem Compound ID
45381907
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Antagonist [532519]
References
Ref 523372ClinicalTrials.gov (NCT01302873) Study of BGG492 in Patients With Chronic Subjective Tinnitus. U.S. National Institutes of Health.
Ref 532519BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy. Expert Opin Investig Drugs. 2014 Jan;23(1):107-13.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.